Researchers at Leipzig University and the University of Gothenburg have developed a novel approach to assessing an individual's risk of metabolic diseases such as diabetes or fatty liver disease more precisely. Instead of ...
Jan 7, 2026
0
44
Obesity is a growing national health crisis, with nearly 40% of U.S. adults affected and about 10% having a severe form of the disease. Although weight-loss drugs are surging in popularity and have reshaped conversations ...
Jan 5, 2026
0
14
Weight gain is common in women during perimenopause and after menopause, but the physical changes underlying it start much earlier in adulthood. Daniela Hurtado Andrade, M.D., Ph.D., an endocrinologist and obesity expert ...
Dec 30, 2025
0
15
A new USC study shows teens with higher blood levels of per- and polyfluoroalkyl substances (PFAS) measured before bariatric surgery had smaller improvements in blood sugar over five years, including fasting glucose and hemoglobin ...
Dec 5, 2025
0
29
The Trump administration is making a significant effort to reduce the cost of weight loss drugs. Its agreement with pharmaceutical giants, announced Nov. 6, 2025, will reduce the monthly prices of these medications by hundreds ...
Nov 22, 2025
0
24
People who have used GLP-1 medications—better known by their brand names like Ozempic, Mounjaro or Wegovy—have likely seen meaningful changes in their health, such as improved blood sugar, lower blood pressure and weight ...
Nov 20, 2025
0
11
Combining bariatric surgery with weight loss medication can help people who need to lose more weight post-surgery, Monash University and Alfred Health-led research has found.
Nov 10, 2025
0
23
New research findings show a significant increase in the use of weight loss drugs among patients undergoing metabolic and bariatric surgery, signaling an evolution in the management of obesity and type 2 diabetes.
Oct 3, 2025
0
15
The popularity of glucagon-like peptide-1 (GLP-1) agonists like Ozempic, Wegovy and Mounjaro has exploded in recent years. Initially approved to treat Type 2 diabetes, the drugs have become the tool of choice for millions ...
Sep 18, 2025
0
14
A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo weight-loss surgery live longer and face fewer serious health problems compared with those treated with GLP-1 receptor agonist ...
Sep 16, 2025
0
115
